Key Takeaways
- • Seattle-area startups raised $1.5 billion across 69 deals in Q1 2026, down 32% in deal count from 104 deals in the prior year quarter, marking the lowest deal volume since 2020 despite stable funding levels.
- • Global venture capital concentrated capital among fewer companies: deal counts fell 17% while funding values increased 40% year-over-year through September 2025, reflecting a "bigger checks, fewer bets" market dynamic driven by investor focus on AI and established winners.
- • Median deal sizes hit five-year highs across pre-seed through Series B stages; deals priced at or below $5 million dropped to 36% from 42.9%, indicating a structural shift toward larger check sizes and away from early-stage funding.
- • Venture funding gap widened between well-capitalized startups and underfunded companies, with investor FOMO and AI sector focus concentrating available capital among a narrower set of companies and sectors.
- • U.S. venture fund formation collapsed 46% in 2024 and 68% from 2021–2024, resulting in fewer institutional investors writing checks and reducing funding availability outside top-tier startups and late-stage rounds.
Summary
Seattle's venture capital market is undergoing a structural consolidation characterized by sharply declining deal counts paired with stable absolute funding levels, signaling a market increasingly focused on larger, more mature investments. Seattle-area startups completed only 69 deals raising $1.5 billion in the first quarter of 2026, down from 104 deals totaling $2.2 billion in the prior-year quarter—a 34% decline in deal volume and the lowest activity since 2020. This compression reflects a broader national trend: global venture funding reached $367 billion across the first nine months of 2025, up 40% year-over-year, yet deal counts fell 17%, demonstrating that capital is flowing to fewer companies at larger check sizes.
The mechanism driving this shift is well-documented across multiple market participants. Median deal sizes have reached five-year highs from pre-seed through Series B stages, while the proportion of deals under $5 million fell to 36% from 42.9%, the lowest level recorded. Available capital is being "divided up among fewer and fewer hands," according to Carta's analysis, with average venture round sizes increasing substantially across all funding stages. This concentration reflects a fundamental reallocation of institutional capital away from early-stage and emerging companies toward proven performers and AI-focused ventures.
Institutional supply-side pressures are reinforcing this dynamic. U.S. venture fund formation experienced severe contraction, with new fund closings declining 46% in 2024 alone and falling 68% cumulatively from 2021 through 2024. Correspondingly, the number of active venture investors writing checks declined 26% over three years, while total LP capital committed to U.S. venture funds fell 22% in 2024 and approximately 60% from two years prior. This investor-side consolidation leaves fewer institutional players deploying capital, thereby reducing funding optionality for companies outside the top tier.
For Seattle startups, the funding gap has widened distinctly between well-capitalized competitors and underfunded sectors. According to Puget Sound Business Journal reporting from April 2026, investor FOMO and concentrated focus on identifying "AI winners" are widening the funding disparity in startup ecosystems. Late-stage financing dominates capital allocation, with Series C and beyond rounds capturing a disproportionate share of available funds. Early-stage companies, particularly those in consumer health, women's health, gaming, and other sectors outside AI, face a more constrained funding environment with fewer VC firms actively deploying capital in their spaces.
The market dynamic reflects selective healing following years of macroeconomic turbulence and rising interest rates. While absolute funding volumes have recovered, the recovery is highly uneven, favoring late-stage companies with proven business models and AI exposure while leaving seed and Series A funding increasingly constrained. This structural shift presents material implications for institutional investors: portfolio construction in venture-backed ecosystems now requires heightened focus on fund manager quality and sector selection, as capital availability for emerging companies has contracted significantly despite headline-level funding growth.
The mechanism driving this shift is well-documented across multiple market participants. Median deal sizes have reached five-year highs from pre-seed through Series B stages, while the proportion of deals under $5 million fell to 36% from 42.9%, the lowest level recorded. Available capital is being "divided up among fewer and fewer hands," according to Carta's analysis, with average venture round sizes increasing substantially across all funding stages. This concentration reflects a fundamental reallocation of institutional capital away from early-stage and emerging companies toward proven performers and AI-focused ventures.
Institutional supply-side pressures are reinforcing this dynamic. U.S. venture fund formation experienced severe contraction, with new fund closings declining 46% in 2024 alone and falling 68% cumulatively from 2021 through 2024. Correspondingly, the number of active venture investors writing checks declined 26% over three years, while total LP capital committed to U.S. venture funds fell 22% in 2024 and approximately 60% from two years prior. This investor-side consolidation leaves fewer institutional players deploying capital, thereby reducing funding optionality for companies outside the top tier.
For Seattle startups, the funding gap has widened distinctly between well-capitalized competitors and underfunded sectors. According to Puget Sound Business Journal reporting from April 2026, investor FOMO and concentrated focus on identifying "AI winners" are widening the funding disparity in startup ecosystems. Late-stage financing dominates capital allocation, with Series C and beyond rounds capturing a disproportionate share of available funds. Early-stage companies, particularly those in consumer health, women's health, gaming, and other sectors outside AI, face a more constrained funding environment with fewer VC firms actively deploying capital in their spaces.
The market dynamic reflects selective healing following years of macroeconomic turbulence and rising interest rates. While absolute funding volumes have recovered, the recovery is highly uneven, favoring late-stage companies with proven business models and AI exposure while leaving seed and Series A funding increasingly constrained. This structural shift presents material implications for institutional investors: portfolio construction in venture-backed ecosystems now requires heightened focus on fund manager quality and sector selection, as capital availability for emerging companies has contracted significantly despite headline-level funding growth.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.